Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: siRNA

August 26, 2025 CD as API / Drug delivery / Pharma applications

Cyclodextrin-Based Nanotransporters as a Versatile Tool to Manage Oxidative Stress-Induced Lung Diseases

Oxidative stress is one of the key elements in lung-related complications such as cystic fibrosis, acute lung injury, pulmonary hypertension,

Continue reading

October 12, 2023 Drug delivery / Pharma applications

Cyclodextrin-Based Arsenal for Anti-Cancer Treatments

Anti-cancer drugs are mostly limited in their use due to poor physicochemical and biopharmaceutical properties. Their lower solubility is the

Continue reading

March 2, 2023 Drug delivery / Pharma applications

Cyclodextrin-Based Arsenal for Anti-Cancer Treatments

After a recent review on applicatipon of CD-based systems in cancer therapy a new review has been published by Kushik’s

Continue reading

January 2, 2019 CD as API / CD derivatives / Cosmetics and toilettry / Drug delivery / Gene delivery / Non-pharma applications / Pharma applications

Cyclodextrin News Year in Review 2018

The CDNews blog was created in July and after a short period of trial it started in September. During this

Continue reading

December 1, 2018 CD derivatives / Gene delivery / Pharma applications

Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery

In the laboratory of C. M. O’Driscoll (University College Cork), an antibody targeted cyclodextrin-based siRNA delivery vector (CD.DSPE-PEGFab) was developed

Continue reading

September 18, 2018 CD derivatives / Gene delivery / Pharma applications

Bridging cyclodextrin to transfect siRNA

The bridging of beta-cyclodextrin with an ammonium linker which bears a hydrophobic substituent efficiently forms supramolecular polymers, avoiding the competing

Continue reading

Recent Posts

  • Comparative Study of Nanosuspensions for Acetogenins Delivery
  • Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
  • Events of American Cyclodextrin Consortium
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
  • Nano-Enabled Toxicity of Pharmaceutical Excipients

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (66)
  • CD as API (347)
  • CD derivatives (410)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (791)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (222)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (400)
  • Other industrial use (106)
  • Pharma applications (1,183)
  • Supramolecular systems (40)
  • Uncategorized (146)

Top Posts

  • Comparative Study of Nanosuspensions for Acetogenins Delivery
  • Polyphenols' encapsulation in cyclodextrins: An updated systematic literature review
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
  • Harnessing Organoid Platforms for Nanoparticle Drug Development
  • A review on sodium sulfobutylether-β-cyclodextrin (SBECD)
  • A new multi-compendia modified beta-cyclodextrin, Kleptose® HPB-LB parenteral grade
  • A sugammadex-analogue, per-6-O-carboxyhexyl-thio-gamma-CD (OKL-1111) is a highly potent and universal reversal agent for anticoagulants
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,473 other subscribers

Loading Comments...